14. Nora JJ, Nora AH, Toews WH: Lithium, Ebstein's anomaly and other congenital heart defects. figure 1 . The basic cycle length (AA interval) is the time distance between the A waves of the high right atrial electrogram. The atrial conduction intervals were determined by measuring the right intra-atrial conduction time, interatrial conduction time and P wave durations. The right intra-atrial conduction time is the time interval from the onset of right atrial activation (the beginning of the P wave or the high right atrial deflection, whichever occurs first) to the low right atrial deflection (HRA-LRA, b. of fig. 1 Student's t-test was used to evaluate the statistical significance between the atrial flutter and control groups. The incidence of prolonged SACTs, CRTs, AH, and HV intervals between the two groups was analyzed with Fisher's exact test (chi-square).
Results
The atrial conduction intervals and effective atrial refractory period data are presented in table 1. The mean basic cycle length was not significantly different between the two groups. The measurements of atrial conduction showed significant prolongation in the atrial flutter group. The mean right intra-atrial conduction time was 50 ± 4.0 msec (mean ± SEM) for the flutter group and 37 ± 3.0 msec for the control group (P < 0.05). The mean interatrial conduction time of the flutter group was more than twice the control value with durations of 92 ± 6.0 msec and 44 ± 4.0 respectively (P < 0.001). It is noteworthy that there was no overlap of the HRA-LA data points between the two groups. The longest HRA-LA value for the control group was 60 msec and the shortest interval in the flutter group was 65 msec. P wave durations were also prolonged for the flutter group at 132 ± 5.0 msec with control P wave durations of 112 ± 4.0 msec (P < 0.01). The AERP was measured in 15 patients of the flutter group and eight patients of the control group and no significant difference was found between the mean values. The slightly shorter (but statistically insignificant) mean AERP of the flutter group is probably secondary to the slight (also insignificant) shortening of the basic cycle length. 7 The incidence of sinus node dysfunction was significantly increased in the atrial flutter group (table 2). Prolongation of the SACT (normal < 205 msec)8 occurred in eight of the 18 atrial flutter patients tested (P < 0.05). The CRT was prolonged (normal < 395 msec)9 in seven of the 19 atrial flutter patients tested (P < 0.05). The incidence of AH and HV prolongation was not significantly higher for the flutter group. Although no increased incidence of A-V node or Hisproximal Purkinje conduction abnormalities was noted, eight of the 21 flutter patients (P < 0.05) had evidence of distal conduction disease (5 LIVCD, 2 LAD, 1 RBBB).
Discussion The presence of prolonged atrial conduction intervals in the atrial flutter patients with normal sized atria strongly suggests the existence of atrial conduction disease. The presence of increased atrial mass secondary to atrial hypertrophy (without chamber enlargement) cannot be excluded as a potential explanation for the prolongation of atrial conduction.'0 However, it is unlikely that a significant increase in the atrial wall musculature would occur without detectable chamber enlargement, or would account for the interatrial conduction times which are greater than two times the control value. The demonstration of an increased incidence of sinus node dysfunction and an increased frequency of distal ventricular conduction diseases supports the concept of the presence of atrial conduction disease. The disease process affecting the atria (more specifically, the preferential conduction system of the atria) probably involved the sinoatrial region and the ventricular conduction system as well. A diffuse fibrodegenerative conduction disease process akin to the processes described by Lev," Lenegre,"2 and Legato et al.2 is the most plausible and unifying explanation for the conduction abnormalities found in the atrial flutter group. Other than one case report"3 showing an increase in the fibrous tissue content of the SA node in a patient with atrial flutter, no histopathologic data are available on atria predisposed to the development of atrial flutter.
It is unlikely that the occurrence of atrial conduction disease in patients who develop atrial flutter represents the simultaneous development of two independent processes. Age-matched controls showed little to no delay of atrial conduction. Studies from our laboratory also showed that patients with paroxysmal atrial tachycardia (A-V re-entry and ectopic atrial focus varieties) did not have significant prolongation of the atrial conduction intervals."4 Preliminary data from our laboratory suggest that patients with atrial fibrillation also show evidence of prolonged atrial conduction, a physiologic manifestation of the histopathologic changes noted in chronic atrial fibrillation"5 and a possible mechanistic link between atrial flutter and fibrillation. It appears that atrial flutter and fibrillation are dysrhythmias which depend on atrial conduction disease for their development, whereas other atrial dysrhythmias do not require the presence of extensive atrial conduction abnormalities.
How atrial conduction disease initiates and sustains atrial flutter is not explained by this study, nor does the study resolve the perpetual controversy of circus movement versus the ectopic focus mechanisms of atrial flutter. Conduction delay of a preferential atrial conduction pathway would shorten the length of loop necessary to sustain a circus movement loop. However, the presence of conduction disease also provides the milieu for the development of ectopic foci of small re-entry loops. Whatever the underlying mechanism may be, it is apparent that atrial conduction disease is a major predisposing factor for the development of atrial flutter.
